Cettire shares

Cettire shares are down over 60% this year as investors follow the leader in selling shares

It hasn’t been a good year for Cettire shares. For a long time after the pandemic, eCommerce was one of…

Big Four Banks are Too Expensive

Some say the Big 4 Banks are Too Expensive, but are they really?

‘The Big Four Banks are Too Expensive’, it is often asserted, both by retail investors and professional analysts alike. Australia’s…

opthea

Opthea (ASX:OPT): Still some way to go, but the wait could pay off in 2025

It has been a few years since investors have paid attention to biotech Opthea (ASX:OPT). Since its stellar Phase 2…

how to value resources stocks?

How to value resources stocks? Here are 3 unique multiples investors can use

The question of how to value resources stocks on the ASX is not an easy one to answer, because there…

iron ore demand from China

Fortescue is reliant on iron ore demand from China, but is the party over?

Iron ore demand from China has been the driving force behind the global iron ore market for the past two…

delisted ASX company

Help: I own a delisted ASX company! What can I do?

If you own shares in a delisted ASX company, you’re probably wondering what to do. Some stocks have a happy…

Where to Next for Bitcoin?

Where to Next for Bitcoin? Here’s where the world’s most famous cryptocurrency might be headed in the next 12 months

Where to Next for Bitcoin? To say Bitcoin (BTC) has been on an interesting journey over the past few months…

Guzman y gomez asx ipo

The Guzman y Gomez ASX IPO gained over 35% on its first trading day – but will the hot run last?

The Guzman y Gomez ASX IPO was a spectacular success. After months of rumours, and a few weeks marketing (and…

share buybacks

Share buybacks: Are they a good sign or a waste of money?

Share buybacks are a controversial topic amongst investors. Some say it is a waste of money, others will welcome it…

AFT Pharmaceuticals

AFT Pharmaceuticals (ASX:AFP): A gem of a dual-listed healthcare company

AFT Pharmaceuticals (ASX:AFP) may not spring to mind as the best company to have come out of New Zealand. Many…

Can Tabcorp’s nеw boss improve the stock’s dwindling odds?

Tabcorp (ASX: TAH) has had a dog of a year, with its share price dropping roughly 40% in the last…

bitcoin ETFs

The dream of Bitcoin ETFs on the ASX will soon become a reality, but here’s what investors need to know

For a long time, the concept of bitcoin ETFs has been little more than a pipedream, until the SEC finally…

buy Apple shares from Australia

Should I buy Apple shares from Australia? Can the US$3.3tn behemoth grow any further?

Investors asking themselves, ‘Should I buy Apple shares from Australia,’ are not just considering buying shares any company, but the…

ASX CHESS replacement

The ASX CHESS Replacement: Will the excruciating wait finally be over by the end of the 2020s?

The long-promised ASX CHESS replacement has been a saga that likely has more twists and turns to come. Despite prior…

AI

AI Wars: Which Tech Giant’s Artificial Intelligence is better?

Artificial Intelligence (AI) is no longer just a futuristic concept—it’s here, transforming our daily lives from the way we commute…